Surrozen, Inc. (SRZN)Healthcare | Biotechnology | South San Francisco, United States | NasdaqCM
22.42 USD
-1.59
(-6.622%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 22.42 |
Hot Take ↕ | Aug. 22, 2026, 5:43 a.m. EDT
The immediate outlook is neutral-to-slightly-bearish due to a lack of clear directional momentum and a statistically weak short-term forecast, despite the stock hovering near key resistance levels. However, the long-term investment case is severely compromised by a catastrophic multi-year price collapse; the asset has lost nearly 90% of its value over the last four years, with three consecutive years of negative annual returns ending just recently. While the most recent year showed a sharp recovery, the persistent structural decline and deteriorating fundamentals—evidenced by negative earnings, negative operating margins, and negative book value—indicate a business struggling to generate sustainable value. There is no dividend income to offset these risks, making this a high-risk speculative vehicle rather than a viable core holding. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.077893 |
| AutoARIMA | 0.080349 |
| AutoETS | 0.080350 |
| AutoTheta | 0.106083 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 39% |
| H-stat | 0.20 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.405 |
| Excess Kurtosis | -0.14 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 1.142 |
| Market Cap | 263,514,768 |
| Forward P/E | -5.36 |
| Beta | 0.56 |
| Previous Name | Consonance-HFW Acquisition Corp. |
| Website | https://www.surrozen.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.9488636 |
| Address1 | 171 Oyster Point Boulevard |
| Address2 | Suite 400 |
| All Time High | 210.0 |
| All Time Low | 4.5 |
| Ask | 29.31 |
| Ask Size | 2 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 178,460 |
| Average Daily Volume3 Month | 203,472 |
| Average Volume | 203,472 |
| Average Volume10Days | 178,460 |
| Beta | 0.559 |
| Bid | 16.85 |
| Bid Size | 2 |
| Book Value | -18.603 |
| City | South San Francisco |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 22.42 |
| Current Ratio | 12.141 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 23.6 |
| Day Low | 22.15 |
| Display Name | Surrozen |
| Earnings Quarterly Growth | 0.262 |
| Earnings Timestamp End | 1,746,821,116 |
| Earnings Timestamp Start | 1,746,821,116 |
| Ebitda | -44,128,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -3.802 |
| Enterprise To Revenue | 14.577 |
| Enterprise Value | 167,791,776 |
| Eps Current Year | -9.14 |
| Eps Forward | -4.18667 |
| Eps Trailing Twelve Months | -37.41 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 23.1278 |
| Fifty Day Average Change | -0.7077999 |
| Fifty Day Average Change Percent | -0.030603858 |
| Fifty Two Week Change Percent | 94.88636 |
| Fifty Two Week High | 35.0 |
| Fifty Two Week High Change | -12.58 |
| Fifty Two Week High Change Percent | -0.35942855 |
| Fifty Two Week Low | 11.25 |
| Fifty Two Week Low Change | 11.17 |
| Fifty Two Week Low Change Percent | 0.99288887 |
| Fifty Two Week Range | 11.25 - 35.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,610,375,400,000 |
| Float Shares | 4,617,855 |
| Forward Eps | -4.18667 |
| Forward P E | -5.3550916 |
| Free Cashflow | -21,751,750 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 44 |
| Fullday Change | -1.59 |
| Fullday Change Percent | -6.62224 |
| Fullday Price | 22.42 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | -2.00382 |
| Gross Profits | -23,066,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03137 |
| Held Percent Institutions | 1.04852 |
| Implied Shares Outstanding | 11,753,558 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-08-12 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,702,512,000 |
| Last Split Factor | 1:15 |
| Long Business Summary | Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6, or IL-6 for the treatment of DME/wet AMD/uveitic macular edema; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of patients with idiopathic pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California. |
| Long Name | Surrozen, Inc. |
| Market | us_market |
| Market Cap | 263,514,768 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_401948183 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -324,564,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 282,202,927 |
| Number Of Analyst Opinions | 5 |
| Open | 23.52 |
| Operating Cashflow | -34,762,000 |
| Operating Margins | -2.074 |
| Payout Ratio | 0.0 |
| Phone | 650 489 9000 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 22.42 |
| Post Market Time | 1,787,947,805 |
| Prev Name | Consonance-HFW Acquisition Corp. |
| Previous Close | 24.01 |
| Price Eps Current Year | -2.452954 |
| Price Hint | 2 |
| Price To Book | -1.205182 |
| Price To Sales Trailing12 Months | 22.892431 |
| Profit Margins | 0.0 |
| Quick Ratio | 11.879 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -1.59 |
| Regular Market Change Percent | -6.62224 |
| Regular Market Day High | 23.6 |
| Regular Market Day Low | 22.15 |
| Regular Market Day Range | 22.15 - 23.6 |
| Regular Market Open | 23.52 |
| Regular Market Previous Close | 24.01 |
| Regular Market Price | 22.42 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 239,362 |
| Return On Assets | -0.25395 |
| Revenue Growth | 4.086 |
| Revenue Per Share | 1.142 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 11,753,558 |
| Shares Percent Shares Out | 0.1066 |
| Shares Short | 1,253,140 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 970,957 |
| Short Name | Surrozen, Inc. |
| Short Percent Of Float | 0.192 |
| Short Ratio | 4.68 |
| Source Interval | 15 |
| State | CA |
| Symbol | SRZN |
| Target High Price | 51.0 |
| Target Low Price | 40.0 |
| Target Mean Price | 44.6 |
| Target Median Price | 44.0 |
| Total Cash | 102,039,000 |
| Total Cash Per Share | 8.682 |
| Total Debt | 6,316,000 |
| Total Revenue | 11,511,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -37.41 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 23.781836 |
| Two Hundred Day Average Change | -1.3618355 |
| Two Hundred Day Average Change Percent | -0.057263684 |
| Type Disp | Equity |
| Volume | 239,362 |
| Website | https://www.surrozen.com |
| Zip | 94,080 |